Status:
COMPLETED
Study of ONO-2506 in Patients With Acute Ischemic Stroke
Lead Sponsor:
Ono Pharmaceutical Co. Ltd
Conditions:
Stroke
Eligibility:
All Genders
20-79 years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this study is to determine the efficacy and safety of ONO-2506 compared to placebo in patients with acute ischemic stroke.
Eligibility Criteria
Inclusion
- Subjects who have a clinical diagnosis of acute ischemic stroke
- Subjects within 72 hours after onset of the stroke
- Other inclusion criteria may apply.
Exclusion
- Subjects who are scheduled to have surgical operations likely to affect the prognosis (including intravascular surgery and circulatory reconstruction)
- Subjects who are pregnant or lactating, or who have child-bearing potential, or who wish to become pregnant.
- Other exclusion criteria may apply.
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2008
Estimated Enrollment :
757 Patients enrolled
Trial Details
Trial ID
NCT00229177
Start Date
September 1 2005
End Date
September 1 2008
Last Update
June 13 2012
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Chugoku Region Facility
Chugoku, Japan
2
Chubu Region Facility
Chūbu, Japan
3
Hokkaido Region Facility
Hokkaido, Japan
4
Hokuriku Region Facility
Hokuriku, Japan